Report Materials
Executive Summary
In a follow-up audit of Alabama's Medicaid drug rebate program, we found that, as of June 30, 2006, the State agency implemented the recommendations from our previous audit related to the collection of interest and the utilization of write-off criteria for dispute resolution. In addition, the State agency established controls over collecting rebates on single source drugs administered by physicians. Therefore, we did not offer any recommendations.
Notice
This report may be subject to section 5274 of the National Defense Authorization Act Fiscal Year 2023, 117 Pub. L. 263.